Michael Mancino
Credentials | Arkansas Medical License |
---|
| Diplomate American Board of Psychiatry and Neurology |
---|
| DiplomateAmerican Board of Preventive Medicine in Addiction Medicine |
---|
Title | Professor |
---|
Institution | University of Arkansas for Medical Sciences |
---|
Department | PSY Psychiatry, College of Medicine |
---|
Division | PSY PRI Faculty |
---|
Address | 4TH FL Psychiatric Research Institute 4224 Shuffield Dr. Mail Slot # 843 Little Rock AR 72205
|
---|
Phone | 501-526-8440 |
---|
vCard | Download vCard |
---|
|
|
|
Overview Dr. Michael J. Mancino is a Professor in the UAMS Department of Psychiatry and the program director of the Center for Addiction Services and Treatment in the Psychiatric Research Institute.
Affiliation College on Problems of Drug Dependence American Society of Addiction Medicine Arkansas Medical Society American Psychiatric Association Arkansas Psychiatric Association
Biography President Arkansas Medical Foundation
Secretary Treasurer Arkansas Medical Foundation Board of Directors
Chairperson UAMS Medical Staff Health Committee
University of Akron, Akron, Ohio | BS | 05/1984 | Life Sciences | Northeast Ohio Medical University, Rootstown, Ohio | MD | 05/1988 | Medicine | University Hospital, Louisville, Kentuck | Intern | 06/1989 | General Surgery | University of Mississippi Medical Center, Jackson, Mississippi | Resident | 06/1997 | Neurological Surgery | UAMS, Little Rock, Arkansas | Resident | 05/2004 | Psychaitry | UAMS, Little Rock, Arkansas | NIMH Postdoctoral Fellow | 05/2004 | Health Services Research |
2022 - 2023 | Soiree Top Docs Addiction Medicine , UAMS | 2019 | Outstanding Mentor , AACAP | 2019 | Leonard Tow Humanism in Medicine, Arnold P. Gold Foundation | 2010 - 2011 | Alcohol Medical Scholars Recipient, University of California, San Diego | 2008 | Early Career Investigator , College on Problems of Drug Dependence | 2004 | Alpha Onega Alpha, Housestaff Member, 2004 | 2003 | Excellence in Medical Student Teaching, UAMS | 1986 - 1987 | Specht Medical EDucation Foundation of College of Medicine Academic Scholarship, Northeast Ohio Medical University | 1984 | Jason, Sumner and Conme College of Medicine Academic Scholarship, Northeast Ohio Medical University | 1982 - 1983 | University of Akron Association Academic Scholarship, University of Akron |
Research 4600054281 (MANCINO, MICHAEL)May 1, 2024 - Sep 30, 2024 Substance Abuse & Mental Health Services Administration - Pass Through: Arkansas Department of Health & Human Services SOR III MAT Training Carryover FY24 Role: Principal Investigator |
| 4600054282 (MANCINO, MICHAEL)May 1, 2024 - Sep 30, 2024 Substance Abuse & Mental Health Services Administration - Pass Through: Arkansas Department of Health & Human Services Carryover SOR III Emergency Department FY24 Role: Principal Investigator |
| 4600054336 (MANCINO, MICHAEL)May 1, 2024 - Sep 30, 2024 Substance Abuse & Mental Health Services Administration - Pass Through: Arkansas Department of Health & Human Services MATRIARC Carryforward SORIII FY2024 Role: Principal Investigator |
| 4600054280 (MANCINO, MICHAEL)May 1, 2024 - Sep 29, 2024 Substance Abuse & Mental Health Services Administration - Pass Through: Arkansas Department of Health & Human Services SOR III Carryforward Justice Involved Individuals Role: Principal Investigator |
| 4600053332 (MANCINO, MICHAEL)Oct 1, 2023 - Sep 30, 2025 Substance Abuse & Mental Health Services Administration - Pass Through: Arkansas Department of Human Services ADAP Substance Abuse Treatment Clinic FY24 Role: Principal Investigator |
| 4600051890 (MANCINO, MICHAEL)Jan 1, 2023 - Sep 30, 2025 Substance Abuse & Mental Health Services Administration - Pass Through: Arkansas Department of Human Services SOR III Emergency Department Naloxone Project Role: Principal Investigator |
| R01DA048022 (JAMES, GEORGE ANDREW)Aug 1, 2021 - May 31, 2026 NIH Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder Role: Co-Investigator |
| 3UG1DA013035 (MANCINO, MICHAEL)Jul 1, 2021 - Feb 28, 2026 NIH/Nat. Inst. on Drug Abuse - Pass Through: New York University CTN-0100: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) Role: Principal Investigator |
| 4600047964 (MANCINO, MICHAEL)Nov 20, 2020 - Sep 29, 2022 Substance Abuse & Mental Health Services Administration - Pass Through: Arkansas Department of Human Services State Opioid Response Grant for MATRIARC and ECHO Role: Principal Investigator |
| 4600047965 (MANCINO, MICHAEL)Nov 20, 2020 - Sep 29, 2022 Substance Abuse & Mental Health Services Administration - Pass Through: Arkansas Department of Human Services Medication-Assisted Treatment Services using Opioid Use Disorder Role: Principal Investigator |
| UG1DA020024 (OLIVETO, ALISON)Jun 1, 2020 - Feb 28, 2025 NIH/Nat. Inst. on Drug Abuse - Pass Through: University of Texas Southwestern Medical Center Clinical Trials Network: The Big South/West Node Role: Principal Investigator |
| R21DA045246 (WRIGHT, PATRICIA B)Sep 30, 2018 - Aug 31, 2021 NIH Improving Treatment Strategies for Prescription Opioid Use Disorder- Resubmission Role: Co-Investigator |
| 4600036835 (MANCINO, MICHAEL)Jul 1, 2016 - Sep 30, 2023 Substance Abuse & Mental Health Services Administration - Pass Through: Arkansas Department of Health & Human Services ADAP Substance Abuse Treatment Clinic - Continuation - Continuation - Continuation - Continuation - Continuation Role: Principal Investigator |
| R01DA039088 (OLIVETO, ALISON)Jul 15, 2015 - May 31, 2021 NIH/Nat. Inst. on Drug Abuse Improving Treatment Outcomes for Prescription Opioid Dependence - Continuation - Continuation - Continuation - Continuation Role: Co-Principal Investigator |
| R01DA039088 (OLIVETO, ALISON)Jul 15, 2015 - May 31, 2021 NIH Improving Treatment Outcomes for Prescription Opioid Dependence Role: Co-Principal Investigator |
| R21DA034824 (MANCINO, MICHAEL J)Aug 1, 2013 - Jul 31, 2016 NIH Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence Role: Principal Investigator |
| R21DA034824 (MANCINO, MICHAEL J)Aug 1, 2013 - Jul 31, 2016 NIH Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence Role: Principal Investigator |
| R21DA031837 (OLIVETO, ALISON)May 1, 2012 - Aug 31, 2015 NIH/Nat. Inst. on Drug Abuse Impact of CYP2D6 Phenotype on Response to Methamphetamine in Humans Role: Co-Investigator |
| P50DA018197 (OLIVETO, ALISON)Sep 1, 2009 - May 31, 2014 NIH/Nat. Inst. on Drug Abuse - Pass Through: Baylor College of Medicine Efficacy of Carvedilol in Recently-Abstinent Psychostimulant Dependent Patients Role: Co-Investigator |
| R01DA026916 (GENTRY, WILLIAM)Sep 1, 2009 - Jul 31, 2013 NIH/Nat. Inst. on Drug Abuse Monoamine Antagonist Therapies for Methamphetamine Abuse Role: Co-Investigator |
| 33 (CARGILE, CHRISTOPHER)Jul 1, 2007 - Jun 30, 2008 AR Dept of Human Services/Division of Behavioral Health Services University of Arkansas for Medical Sciences - Substance Abuse Treatment Clinic Role: Principal Investigator |
| R01DA019999 (KILTS, CLINT)May 1, 2007 - Feb 28, 2012 NIH/Nat. Inst. on Drug Abuse AN FMRI STUDY OF THE IMPACT OF STRESS ON DRUG ADDICTION Role: Co-Investigator |
| P20RR020146 (GARCIA-RILL, EDGAR E.)Sep 16, 2004 - Apr 30, 2014 NIH Center for Translational Neuroscience Role: Co-Investigator |
| SASDeptofHS#33 (CARGILE, CHRISTOPHER)Jul 1, 2004 - Jun 30, 2005 Arkansas Department of Health University of Arkansas for Medical Sciences - Substance Abuse Treatment Clinic (formerly Don McMillan) Role: Principal Investigator |
| 33-04 (CARGILE, CHRISTOPHER S)Jul 1, 2003 - Jun 30, 2014 Arkansas Department of Health & Human Services University of Arkansas for Medical Sciences - Substance Abuse Treatment Clinic Role: Principal Investigator |
| SAS Dept of HS #33-04 (CARGILE, CHRISTOPHER S)Jul 1, 2003 - Jun 30, 2014 Arkansas Department of Health & Human Services University of Arkansas for Medical Sciences - Substance Abuse Treatment Clinic Role: Principal Investigator |
Outreach Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
Don't see publications published under other names? Login to add alternative names.
-
Pro G, Hayes C, Mancino M. Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge. Drug Alcohol Depend. 2024 Sep 01; 262:111403. PMID: 39084112.
-
Pro G, Cantor J, Buttram M, Brown CC, Gu M, Mancino M, Zaller N. Geographic and Racial/Ethnic Differences in Access to Methamphetamine Detoxification Services, United States, 2021. Med Care. 2024 Jul 01; 62(7):464-472. PMID: 38761164.
-
Tsai PF, Oliveto AH, Landes RD, Mancino MJ. Characteristics of patients undergoing medication-assisted -treatment for opioid use disorder and their interest in Tai Chi practice. J Opioid Manag. 2023 Jul-Aug; 19(4):329-341. PMID: 37644791.
-
Thompson RG, Bollinger M, Mancino MJ, Hasin D, Han X, Bush KA, Kilts CD, James GA. Smartphone intervention to optimize medication-assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial. Trials. 2023 Apr 04; 24(1):255. PMID: 37016394.
-
Thompson RG, Bollinger M, Mancino M, Hasin D, Han X, Bush KA, Kilts CD, James GA. Smartphone intervention to optimize medication assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial. Res Sq. 2023 Feb 15. PMID: 36824884.
-
Gokarakonda SB, Boydstun JM, Yilanli M, Han X, Kumar N, Oliveto AH, Mancino MJ. Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program. Am J Addict. 2022 05; 31(3):219-225. PMID: 35243715.
-
Thompson RG, Oliveto A, Thostenson JD, Wilson MP, McGaugh J, Mancino MJ. Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial. J Psychopharmacol. 2021 11; 35(11):1420-1430. PMID: 34697965.
-
Phillips SJ, Oliveto A, Mancino MJ, Hendrickson HP. Development and validation of a rapid liquid chromatography/tandem mass spectrometry method to quantitate gabapentin and buprenorphine in human serum. Rapid Commun Mass Spectrom. 2021 Jul 31; 35(14):e9104. PMID: 33860565.
-
Coker JL, Ray-Griffith SL, McLeod C, Han X, Mancino M, Kearns GL, Stowe ZN. Clearance of buprenorphine during pregnancy and neonatal outcomes. Arch Womens Ment Health. 2021 12; 24(6):933-939. PMID: 33864131.
-
Kumar N, Mancino MJ, Thostenson JD, McGaugh J, Oliveto AH. Feasibility and Preliminary Efficacy of Isradipine During Outpatient Buprenorphine Stabilization and Detoxification: A Pilot Randomized, Placebo-Controlled Trial. Subst Abuse. 2020; 14:1178221820970926. PMID: 33281447.
-
Wilson MP, Cucciare MA, Porter A, Chalmers CE, Mullinax S, Mancino M, Oliveto AH. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids. Am J Emerg Med. 2020 03; 38(3):503-507. PMID: 31221474.
-
Nahata R, Mancino MJ, Thostenson J, Oliveto AH. Survey of Treatment Preferences for Opioid Use Disorder. Jacobs J Addict Ther. 2018; 5(3). PMID: 31131330.
-
Bashiri M, Mancino MJ, Stanick VA, Thostenson J, Kosten TR, Oliveto AH. Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials. Am J Addict. 2017 Dec; 26(8):807-814. PMID: 29115703.
-
Kumar N, Stowe ZN, Han X, Mancino MJ. Impact of early childhood trauma on retention and phase advancement in an outpatient buprenorphine treatment program. Am J Addict. 2016 10; 25(7):542-8. PMID: 27629823.
-
Christensen DR, Landes RD, Jackson L, Marsch LA, Mancino MJ, Chopra MP, Bickel WK. Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence. J Consult Clin Psychol. 2014 Dec; 82(6):964-72. PMID: 25090043.
-
Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. J Clin Psychopharmacol. 2014 Apr; 34(2):234-9. PMID: 24525654.
-
Kaley S, Mancino MJ, Messias E. Sadness, suicide, and drug misuse in Arkansas: results from the Youth Risk Behavior Survey 2011. J Ark Med Soc. 2014 Feb; 110(9):185-6. PMID: 24719998.
-
Sanders NC, Mancino MJ, Gentry WB, Guise JB, Bickel WK, Thostenson J, Oliveto AH. Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure. Exp Clin Psychopharmacol. 2013 Aug; 21(4):294-302. PMID: 23855333.
-
Atkinson TS, Sanders N, Mancino M, Oliveto A. Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients. J Addict Med. 2013 Jul-Aug; 7(4):243-8. PMID: 23648640.
-
Oliveto A, Mancino M, Sanders N, Cargile C, Benjamin Guise J, Bickel W, Brooks Gentry W. Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure. Eur J Pharmacol. 2013 Sep 05; 715(1-3):424-35. PMID: 23524089.
-
Oliveto A, Poling J, Mancino MJ, Williams DK, Thostenson J, Pruzinsky R, Gonsai K, Sofuoglu M, Gonzalez G, Tripathi S, Kosten TR. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction. 2012 Jan; 107(1):131-41. PMID: 21707811.
-
Mancino MJ, Gentry BW, Feldman Z, Mendelson J, Oliveto A. Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study. Am J Drug Alcohol Abuse. 2011 Mar; 37(2):131-6. PMID: 21219261.
-
Bickel WK, Jones BA, Landes RD, Christensen DR, Jackson L, Mancino M. Hypothetical intertemporal choice and real economic behavior: delay discounting predicts voucher redemptions during contingency-management procedures. Exp Clin Psychopharmacol. 2010 Dec; 18(6):546-52. PMID: 21186929.
-
Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, Gonsai K, Cargile C, Sofuoglu M, Chopra MP, Gonzalez-Haddad G, Carroll KM, Kosten TR. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend. 2011 Jan 15; 113(2-3):184-91. PMID: 20828943.
-
Mancino M, Curran G, Han X, Allee E, Humphreys K, Booth BM. Predictors of attrition from a national sample of methadone maintenance patients. Am J Drug Alcohol Abuse. 2010 May; 36(3):155-60. PMID: 20465373.
-
Mancino MJ, McGaugh J, Feldman Z, Poling J, Oliveto A. Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis. Am J Addict. 2010 Mar-Apr; 19(2):169-77. PMID: 20163389.
-
Mancino MJ, McGaugh, J, Feldman, Z, Poling, J, Oliveto, A. Effect of PTSD diagnosis and contingency management procedures on cocaine use in opioid-dependent cocaine abusers maintained on LAAM: A retrospective analysis. American Journal on Addictions. 2010; 19(2):169-177.
-
McGaugh J, Mancino MJ, Feldman Z, Chopra MP, Gentry WB, Cargile C, Oliveto A. Open-label pilot study of modafinil for methamphetamine dependence. J Clin Psychopharmacol. 2009 Oct; 29(5):488-91. PMID: 19745650.
-
Chopra MP, Feldman Z, Mancino MJ, Oliveto A. Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis. Pharmacol Biochem Behav. 2008 Oct; 90(4):787-96. PMID: 18585405.
-
Mancino MJ, Pyne JM, Tripathi S, Constans J, Roca V, Freeman T. Quality-adjusted health status in veterans with posttraumatic stress disorder. J Nerv Ment Dis. 2006 Nov; 194(11):877-9. PMID: 17102715.
-
Smith GR, Burnam MA, Mosley CL, Hollenberg JA, Mancino M, Grimes W. Reliability and validity of the substance abuse outcomes module. Psychiatr Serv. 2006; 57(10):1452 - 1460.
-
Mancino M, Cunningham MR, Davidson P, Fulton RL. Identification of the motor vehicle accident victim who abuses alcohol: an opportunity to reduce trauma. J Stud Alcohol. 1996; 57(6):652 - 658.
-
Fulton RL, Everman D, Mancino M, Raque G. Ritual head computed tomography may unnecessarily delay lifesaving trauma care. Surg Gynecol Obstet. 1993; 176(4):327 - 332.
-
Fulton RL, Flynn WJ, Mancino M, Bowles D, Cryer HM. Brain injury causes loss of cardiovascular response to hemorrhagic shock. J Invest Surg. 1993; 6(2):117 - 131.
-
Kulkarni PS, Mancino M. Studies on intraocular inflammation produced by intravitreal human interleukins in rabbits. Exp Eye Res. 1993; 56(3):275 - 279.
-
Mancino, MJ, Ohia EO, Kulkarni P. A Comparative Study between Cod Liver Oil and Liquid Lard Intake on Intraocular Pressure in Rabbits. Prostaglandins Leukot Essent Fatty Acids. 1992; 45(3):239-243.
-
Ohia EO, Mancino M, Kulkarni PS. Effects of steroids and immunosuppressive drugs on endotoxin-uveitis in rabbits. J Ocul Pharmacol. 1992; 8(4):295 - 307.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
1992 | 2 | 1993 | 3 | 1996 | 1 | 2006 | 2 | 2008 | 1 | 2009 | 1 | 2010 | 5 | 2011 | 2 | 2013 | 3 | 2014 | 3 | 2016 | 1 | 2017 | 1 | 2018 | 1 | 2019 | 1 | 2020 | 1 | 2021 | 3 | 2022 | 1 | 2023 | 3 | 2024 | 2 |
To return to the timeline, click here.
|
Mancino's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|